Overview
Amado Zurita is an Oncologist in Houston, Texas. Dr. Zurita is highly rated in 9 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1515 Holcombe Blvd Unit 1374, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Hagop Kantarjian is an Oncologist in Houston, Texas. Dr. Kantarjian is highly rated in 47 conditions, according to our data. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of Texas MD Anderson Cancer Center
Naval Daver is an Oncologist in Houston, Texas. Dr. Daver is highly rated in 40 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
UT MD Anderson Cancer Center
Neeta Somaiah is an Oncologist in Houston, Texas. Dr. Somaiah is highly rated in 28 conditions, according to our data. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Hepato-Pancreato-Biliary Surgery.
Frequently Asked Questions about Dr. Amado Zurita
How do I make an appointment with Dr. Amado Zurita?
You can book an appointment with Dr. Amado Zurita by calling their office at 713-792-2830. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Amado Zurita a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amado Zurita is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Amado Zurita specialize in?
While Dr. Amado Zurita is a Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Amado Zurita participate in research or clinical trials?
Yes. Dr. Amado Zurita has published 11 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Amado Zurita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Amado Zurita accept my insurance?
Dr. Amado Zurita accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-792-2830 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Zurita isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Zurita isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Zurita isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Zurita isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Zurita isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Zurita isAdvanced. Learn about Familial Wilms Tumor 2.
- Renal Cell Carcinoma (RCC)Dr. Zurita isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorDr. Zurita isAdvanced. Learn about Wilms Tumor.
- Experienced
- Bladder CancerDr. Zurita isExperienced. Learn about Bladder Cancer.
- Lymphofollicular HyperplasiaDr. Zurita isExperienced. Learn about Lymphofollicular Hyperplasia.
- Metastatic Brain TumorDr. Zurita isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Zurita isExperienced. Learn about Metastatic Pleural Tumor.
- Muscle Invasive Bladder CancerDr. Zurita isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Zurita isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.